Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples